- Home
- JKS vs YDES Comparison
JKS vs YDES Comparison
Compare JKS & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JKS | YDES |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | China | Taiwan |
| Employees | N/A | N/A |
| Industry | Semiconductors | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | JKS | YDES |
|---|---|---|
| Price | $27.44 | $12.24 |
| Analyst Decision | Sell | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.49 | N/A |
| AVG Volume (30 Days) | ★ 490.9K | 87.8K |
| Earning Date | 11-17-2025 | 09-30-2025 |
| Dividend Yield | ★ 4.77% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,641,756,390.00 | $510,360.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $30.78 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 45.76 |
| 52 Week Low | $13.42 | $5.30 |
| 52 Week High | $31.88 | $31.00 |
Technical Indicators
Market Signals| Indicator | JKS | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 56.27 | N/A |
| Support Level | $26.63 | N/A |
| Resistance Level | $28.70 | N/A |
| Average True Range (ATR) | 1.23 | 0.00 |
| MACD | 0.14 | 0.00 |
| Stochastic Oscillator | 74.61 | 0.00 |
Price Performance
Historical ComparisonAbout JKS JinkoSolar Holding Company Limited (each representing 4)
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific, and the Rest of the world.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.